Morgan Stanley Resumes IBM (IBM) at Overweight

Go back to Morgan Stanley Resumes IBM (IBM) at Overweight

IBM (IBM) PT Raised to $175 at Nomura/Instinet

August 5, 2019 6:06 AM EDT

Nomura/Instinet analyst Jeffrey Kvaal raised the price target on IBM (NYSE: IBM) to $175.00 (from $165.00) while maintaining a Buy rating.

The analyst comments "IBM capped a full-throated avowal of its Red Hat deal by lifting its mid-term sales growth target from the low... More